Are anti-interferon antibodies the cause of failure in: chronic HCV hepatitis treatment?



Document title: Are anti-interferon antibodies the cause of failure in: chronic HCV hepatitis treatment?
Journal: The brazilian journal of infectious diseases
Database: PERIÓDICA
System number: 000290834
ISSN: 1413-8670
Authors: 1




Institutions: 1Universidade de Sao Paulo, Faculdade de Medicina, Sao Paulo. Brasil
Year:
Season: Feb
Volumen: 8
Number: 1
Pages: 10-17
Country: Brasil
Language: Inglés
Document type: Artículo
Approach: Caso clínico
English abstract A follow-up study was made of 94 chronic hepatitis C patients at a hepatitis clinic in Brazil, after interferon alpha (IFN-alpha) therapy, to determine the influence of anti-interferon antibodies on treatment outcome. Patients diagnosed as having chronic hepatitis C, confirmed by PCR (HCV RNA) and liver biopsy, were treated with interferon alpha 2a or 2b for at least six months, and were followed up for 24 weeks after termination of treatment in order to assess biochemical, virological and clinical pathology responses. Only 6% of the 94 patients developed anti-IFN antibodies, 70% presented a biochemical response and 23% maintained a sustained virological response. Clinical evaluation revealed that in only 2 patients was there progression of fibrosis; the necro-inflammatory score indicated that 72% maintained the same activity, 12% had worsening necro-inflammatory activity, and the remaining 16% had decreased activity. There was no significant correlation of demographic and laboratory variables with levels of anti-interferon antibodies. Similarly, biochemical and virological responses were not influenced by anti-interferon antibodies. Multivariate analysis by logistic regression revealed that clinical pathological parameters, staging and necro-inflammatory activity did not influence the response to the virus
Disciplines: Biología,
Química
Keyword: Inmunología,
Virus,
Bioquímica,
Interferón alfa,
Anticuerpos,
Hepatitis crónica,
Hepatitis C,
Tratamiento
Keyword: Biology,
Chemistry,
Immunology,
Virus,
Biochemistry,
Interferon alpha,
Antibodies,
Chronic hepatitis,
Hepatitis C,
Treatment
Full text: Texto completo (Ver HTML)